Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VM:CC - Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work at Frances Creek Project Site For Notice of Work & Quarry Permitting


VM:CC - Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work at Frances Creek Project Site For Notice of Work & Quarry Permitting

(TheNewswire)

Calgary, AB - TheNewswire - May 31, 2023 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC :VYYRF) (" Voyageur " or the " Corporation ")announces the successful completion ofenvironmental and geotechnical field work at its Frances Creek projectsite. This milestone represents a significant achievement for theCorporation and its 100% owned subsidiary, Voyageur IndustrialMinerals Ltd., as it fulfills both the exploration notice of work forbarite sampling from the surface vein and paves the way for futurequarry permitting.

Undertaken in collaboration with Vast Resource Solutions, a firm basedin Cranbrook, B.C., the detailed site assessment encompassed acomprehensive evaluation of existing baseline conditions within andsurrounding the site. It also involved meticulous collection of soiland rock samples, along with a thorough review of the current andpotential site access road.

The data, samples, and road assessment gathered during this processwill serve as crucial inputs for various planning aspects, includingsite soil handling and reclamation, invasive weed managementpractices, acid rock drainage/metal leaching potential, process areaplanning, and safe access road options.

Voyageur firmly upholds its commitment to environmental stewardshipand sustainability, and this is evident in the work conducted atFrances Creek. All activities have been carried out in strictcompliance with rigorous environmental standards. As part of ourdedication to transparency and regulatory adherence, the findings andoutcomes of the field work will be promptly submitted to the BCMinistry of Mines.

About Voyageur PharmaceuticalsLtd.

Voyageur, a Canadia n publiccompany trading under the symbol VM on the TSXV, is in development ofbarium, iodine and carbon Active Pharmaceutical Ingredients (API) andhigh-performance, cost-effective imaging contrast agents. With astrategic focus on vertically integrating the barium, iodine andcarbon contrast imaging market, Voyageur aims to become a key playerby producing its own barium, iodine, and fullerene minerals.

Our business plan is set to generate immediate cashflow by partnering with established third-party GMP pharmaceuticalmanufacturers in Canada, ensuring the validation of our products byregulatory agencies worldwide. As we solidify our presence in themarket, we will transition into a high-margin domestic manufacturer ofradiology drugs, further expanding our revenue streams.

Voyageur is committed to sustainability andenvironmental stewardship. We envision a future where carbonneutrality is the norm, and to achieve this, we are buildingstate-of-the-art carbon-neutral infrastructure. By investing in carbonneutral energy sources and sustainable manufacturing practices, we aimto become 100% self-sufficient across all our manufacturingactivities. Our commitment to the environment sets us apart as apioneer in the industry.

At the core of our operations, Voyageur owns a 100%interest in two barium sulphate (barite) projects, including theFrances Creek property. Additionally, Voyageur holds interests in ahigh-grade iodine, lithium, and bromine brine project situated inUtah, USA, further bolstering our position in the industry. Voyageurowns a 100% interest in two battery mineral projects which focus oncopper/zinc development.

Our ambitious vision is to become the first verticallyintegrated, carbon-neutral company in the  imaging contrast mediadrug market. By controlling all primary input costs, from the sourcingof raw materials to the final production, we plan to ensure unmatchedquality and cost efficiency. We embody the motto of " From the Earth to the Bottle ," highlighting our commitment to responsible sourcingand manufacturing practices.

For Further Information:

Brent Willis, CEO,

Albert Deslauriers, CFO,

Brent@vpharma.ca

Albert@vpharma.ca

info@vpharma.ca

https://voyageurpharmaceuticals.ca/

Neither the TSX Venture Exchange nor its Regulation Services Provider(as that term is defined in the policies of the TSX Venture Exchange)accepts responsibility for the adequacy or accuracy of this newsrelease.

Cautionary Statement Regarding “Forward-Looking” Information

This news release may contain certain forward-looking information andstatements, including without limitation, statements pertaining to thefuture plans of the Corporation, for Frances Creek and future quarrypermitting . All statements included herein, other than statements ofhistorical fact, are forward-looking information and such informationinvolves various risks and uncertainties. There can be no assurancethat such information will prove to be accurate, and actual resultsand future events could differ materially from those anticipated insuch information. A description of assumptions used to develop suchforward-looking information and a description of risk factors that maycause actual results to differ materially from forward-lookinginformation can be found in the Company's disclosure documents on theSEDAR website at www.sedar.com. Voyageur does not undertake to updateany forward-looking information except in accordance with applicablesecurities laws.

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information

Company Name: Voyageur Pharmaceuticals Ltd.
Stock Symbol: VM:CC
Market: TSXVC
Website: voyageurpharmaceuticals.ca

Menu

VM:CC VM:CC Quote VM:CC Short VM:CC News VM:CC Articles VM:CC Message Board
Get VM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...